Long-term psychiatric and neurologic treatment after a traumatic midbrain lesion

Neurocase

Volumn 3, Issue 2, 1997, Pages 95-103

  Lauterbach, Edward C ^a   Spears, T Elisabeth ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Compulsions; Delirium; Dystonia; Hallucinations; Midbrain; Panic

Indexed keywords

ANTIPARKINSON AGENT; CARBAMAZEPINE; DOPAMINE; GLUTAMIC ACID; NORADRENALIN; PAROXETINE; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRIHEXYPHENIDYL;

ADULT; ARTICLE; BRAIN INJURY; CASE REPORT; CEREBELLUM; CLINICAL FEATURE; COMPULSION; DELIRIUM; DYSTONIA; HALLUCINATION; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MESENCEPHALON; MYOCLONUS; PANIC; PARANOIA; PARKINSONISM; RETICULAR FORMATION; SENSATION; TEGMENTUM; TIME; VISUAL ILLUSION;

EID: 0030833710     PISSN: 13554794     EISSN: None     Source Type: Journal    
DOI: 10.1093/neucas/3.2.95     Document Type: Article

References (60)

1. Aberg-Wistedt A. The antidepressant effects of 5-HT uptake inhibitors. British Journal of Psychiatry Supplement 1989; 8: 32-40.
2. Abraham H, Mamen A. LSD-like panic from risperidone in post-LSD visual disorder. Journal of Clinical Psychopharmacology 1996; 16: 238-41.
3. Baldrati A, Filici B, De Carolis P, Montagna P, Sacquegna T. Subcortical myoclonus from thalamic hemorrhage. Italian Journal of Neurological Sciences 1990; 11: 185-6.
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961; 4: 561-71.
5. Boecker H, Kleinschmidt A, Weindl A, Conrad B, Hanicke W, Frahm J. Dysfunctional activation of subcortical nuclei in palatal myoclonus detected by high-resolution MRI. NMR in Biomedicine 1994; 7: 327-9.
6. Bond M. The psychiatry of closed head injury. In: Brooks N, editor. Closed head injury. Psychological, social, and family consequences. Oxford: Oxford University Press, 1984; 148-78.
7. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35: 73-7.
8. Chiu LP. Transient recurrence of auditory hallucinations during acute dystonia. British Journal of Psychiatry 1989; 155: 110-13.
9. Edlund MJ, Swann AC, Clothier J. Patients with panic attacks and abnormal EEG results. American Journal of Psychiatry 1987; 144: 508-9.
10. Fletcher NA, Stell R, Harding AE, Marsden CD. Degenerative cerebellar ataxia and focal dystonia. Movement Disorders 1988; 3: 336-42.
11. Frieboes RM, Muller U, von Cramon DY. [Symptomatic acoustic hallucinations after traumatic brain damage. Review of the literature and case report.] Nervenarzt 1994; 65: 707-11.
12. Fukutani Y, Takeuchi N, Kobayashi K, Miyazu K, Yamaguchi N, Terada T et al. Striatonigral degeneration combined with olivopontocerebellar atrophy with subcortical dementia and hallucinatory state. Dementia 1995; 6: 235-40.
13. Geller TJ, Bellur SN. Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Annals of Neurology 1987; 21: 602-4.
14. Glennon RA. Do classical hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacology 1990; 3: 509-17.
15. Goldberg E, Antin SP, Bilder RM Jr, Gerstman LJ, Hughes JE, Mattis S. Retrograde amnesia: possible role of mesencephalic reticular activation in long-term memory. Science 1981; 213: 1392-4.
16. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry 1989; 46: 1006-11.
17. Graeff FG, Silveira MC, Nogueira RL, Audi EA, Oliveira RM. Role of the amygdala and periaqueductal gray in anxiety and panic. Behavioral Brain Research 1993; 58: 123-31.
18. Greene P, Shale H, Fahn S. Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Advances in Neurology 1988; 50: 547-56.
19. Griffith ER, Mayer NH. Hypertonicity and movement disorders. In: Rosenthal M, Griffith ER, Bond MR, Miller JD, editors. Rehabilitation of the adult and child with traumatic brain injury. 2nd ed. Philadelphia, PA: FA Davis Co, 1990: 127-47.
20. Hallett M. Is dystonia a sensory disorder? [Editorial]. Annals of Neurology 1995; 38: 139-40.
21. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960; 23: 56-62.
22. Humble M, Wistedt B. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders. International Clinical Psychopharmacology 1992; 6 Suppl 5: 21-39.
23. Joffe RT, Swinson RP. Carbamazepine in obsessive-compulsive disorder. Biological Psychiatry 1987; 22: 1169-71.
24. Johnson MR, Lydiard RB, Ballenger JC. Panic disorder. Pathophysiology and drug treatment. Drugs 1995; 49: 328-44.
25. Jones BE. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 1991; 40: 637-56.
26. Khanna S. Carbamazepine in obsessive-compulsive disorder. Clinical Neuropharmacology 1988; 11: 478-81.
27. Koller WC, editor. Handbook of Parkinson's disease. New York: Marcel Dekker, 1987: 482-8.
28. Kolmel HW. Peduncular hallucinations. Journal of Neurology 1991; 238: 457-9.
29. Kolmel HW. Visual illusions and hallucinations. Bailliéres Clinical Neurology 1993; 2: 243-64.
30. Larsen TA, Dunn HG, Jan JE, Calne DB. Dystonia and calcification of the basal ganglia. Neurology 1985; 35: 533-7.
31. Lauterbach EC. Serotonin reuptake inhibitors, paranoia, and the ventral basal ganglia. Clinical Neuropharmacology 1991; 14: 547-55.
32. Lauterbach EC. The locus coeruleus and anxiety disorders in demented and nondemented familial parkinsonism. [Letter]. American Journal of Psychiatry 1993; 150: 994.
33. Lauterbach EC. Sleep benefit and sleep deprivation in subgroups of depressed patients with Parkinson's disease. [Letter]. American Journal of Psychiatry 1994; 151: 782-3.
34. Lauterbach EC. Fluoxetine, buspirone, myoclonus, and dystonia. [Letter]. American Journal of Psychiatry 1995; 152: 1697.
35. Lauterbach EC, Duvoisin RC. Anxiety disorders in familial parkinsonism. [Letter]. American Journal of Psychiatry 1991; 148: 274.
36. Lauterbach EC, Price ST, Spears TE, Jackson JG, Kirsh AD. Serotonin responsive and nonresponsive diurnal depressive mood disorders and pathological affect in thalamic infarct associated with myoclonus and blepharospasm. Biological Psychiatry 1994; 35: 488-90.
37. Levinson HN. The cerebellar-vestibular predisposition to anxiety disorders. Perceptual and Motor Skills 1989; 68: 323-38.
38. Lou JS, Valls-Sole J, Toro C, Hallett M. Facial action myoclonus in patients with olivopontocerebellar atrophy. Movement Disorders 1994; 9: 223-6.
39. Louis ED, Lynch T, Ford B, Greene P, Bressman SB, Fahn S. Delayedonset cerebellar syndrome. Archives of Neurology 1996; 53: 450-4.
40. Marek GJ, McDougle CJ, Price LH, Seiden LS. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology (Berlin) 1992; 109: 2-11.
41. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology 1981; 31: 645-50.
42. McKee AC, Levine DN, Kowall NW, Richardson EP Jr. Peduncular hallucinosis associated with isolated infarction of the substantia nigra pars reticulata. Annals of Neurology 1990; 27: 500-4.
43. McNamara ME, Fogel BS. Anticonvulsant-responsive panic attacks with temporal lobe EEG abnormalities. Journal of Neuropsychiatry and Clinical Neurosciences 1990; 2: 193-6.
44. Mitoma H, Uchihara T, Yokota T, Furukawa T, Tsukagoshi H. Action myoclonus induced by visually guided movement. Journal of Neurology 1993; 241: 92-5.
45. Murata S, Naritomi H, Sawada T. Musical auditory hallucinations caused by a brainstem lesion. Neurology 1994; 44: 156-8.
46. Nistico G, Nappi G. Locus coeruleus, an integrative station involved in the control of several vital functions. Functional Neurology 1993; 8: 5-25.
47. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Advances in Neurology 1988; 50: 377-84.
48. Olsson JE, Brunk U, Lindvall B, Eeg-Olofsson O. Dopa-responsive dystonia with depigmentation of the substania nigra and formation of Lewy bodies. Journal of the Neurological Sciences 1992; 112: 90-5.
49. Parkes JD. Variability in Parkinson's disease; clinical aspects, causes and treatments. Acta Neurologica Scandinavica Supplement 1983; 95: 27-35.
50. Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV et al. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. Journal of Neurochemistry 1990; 55: 1454-6.
51. Pierce PA, Peroutka SJ. Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors. Neuropsychopharmacology 1990; 3: 503-8.
52. Post RM. Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987: 567-76.
53. Reiman EM, Raichle ME, Robins E, Butler FK, Herscovitch P, Fox P et al. The application of positron emission tomography to the study of panic disorder. American Journal of Psychiatry 1986; 143: 469-77.
54. Rondot P, De Recondo J, Davous P, Vedrenne C. Menzel's hereditary ataxia with slow eye movements and myoclonus. A clinicopathological study. Journal of the Neurological Sciences 1983; 61: 65-80.
55. Rosenblum WI, Greenberg RP, Seelig JM, Becker DP. Midbrain lesions: frequent and significant prognostic feature in closed head injury. Neurosurgery 1981; 9: 613-20.
56. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Advances in Neurology 1976; 14: 215-33.
57. Tondo L, Burrai C, Scamonatti L, Toccafondi F, Poddighe A, Minnai G et al. Carbamazepine in panic disorder. [Letter]. American Journal of Psychiatry 1989; 146: 558-9.
58. Uhde TW, Stein MB, Post RM. Lack of efficacy of carbamazepine in the treatment of panic disorder. American Journal of Psychiatry 1988; 145: 1104-9.
59. Visintini D, Trabattoni G, Tedeschi F, Lechi A, Granella F, Calzetti S. Palatal myoclonus and inferior olive hypertrophy with one-sided cerebellar lesion. Clinico-pathological report of one patient. Functional Neurology 1986; 1: 63-70.
60. von Moltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants. Journal of Clinical Psychopharmacology 1995; 15: 125-31.